Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

T cell receptor-triggered nuclear actin network formation drives CD4+ T cell effector functions.

Tsopoulidis N, Kaw S, Laketa V, Kutscheidt S, Baarlink C, Stolp B, Grosse R, Fackler OT.

Sci Immunol. 2019 Jan 4;4(31). pii: eaav1987. doi: 10.1126/sciimmunol.aav1987.

PMID:
30610013
2.

HIV-1 Nef Disrupts CD4+ T Lymphocyte Polarity, Extravasation, and Homing to Lymph Nodes via Its Nef-Associated Kinase Complex Interface.

Lamas-Murua M, Stolp B, Kaw S, Thoma J, Tsopoulidis N, Trautz B, Ambiel I, Reif T, Arora S, Imle A, Tibroni N, Wu J, Cui G, Stein JV, Tanaka M, Lyck R, Fackler OT.

J Immunol. 2018 Nov 1;201(9):2731-2743. doi: 10.4049/jimmunol.1701420. Epub 2018 Sep 26.

PMID:
30257886
3.

Constitutive CD40 Signaling Calibrates Differentiation Outcomes in Responding B Cells via Multiple Molecular Pathways.

Basu S, Kaw S, D'Souza L, Vaidya T, Bal V, Rath S, George A.

J Immunol. 2016 Aug 1;197(3):761-70. doi: 10.4049/jimmunol.1600077. Epub 2016 Jun 24.

4.

Recruitment of memory B cells to lymph nodes remote from the site of immunization requires an inflammatory stimulus.

Shenoy GN, Chatterjee P, Kaw S, Mukherjee S, Rathore DK, Bal V, Rath S, George A.

J Immunol. 2012 Jul 15;189(2):521-8. doi: 10.4049/jimmunol.1102814. Epub 2012 Jun 6.

5.

Inhibition of terminal differentiation of B cells mediated by CD27 and CD40 involves signaling through JNK.

Satpathy S, Shenoy GN, Kaw S, Vaidya T, Bal V, Rath S, George A.

J Immunol. 2010 Dec 1;185(11):6499-507. doi: 10.4049/jimmunol.0903229. Epub 2010 Oct 25.

7.

Novel selective quinazoline inhibitors of endothelin converting enzyme-1.

Ahn K, Sisneros AM, Herman SB, Pan SM, Hupe D, Lee C, Nikam S, Cheng XM, Doherty AM, Schroeder RL, Haleen SJ, Kaw S, Emoto N, Yanagisawa M.

Biochem Biophys Res Commun. 1998 Feb 4;243(1):184-90.

PMID:
9473502
8.

Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence.

Ehrenreich H, Schuck J, Stender N, Pilz J, Gefeller O, Schilling L, Poser W, Kaw S.

Alcohol Clin Exp Res. 1997 Oct;21(7):1285-93.

PMID:
9347091
9.

Sustained elevation of vasopressin plasma levels in healthy young men, but not in abstinent alcoholics, upon expectation of novelty.

Ehrenreich H, tom Dieck K, Gefeller O, Kaw S, Schilling L, Poser W, Rüther E.

Psychoneuroendocrinology. 1997 Jan;22(1):13-24.

PMID:
9141148
10.

Co-expression of endothelin-1 and endothelin-converting enzyme-1 in patients with chronic rhinitis.

Furukawa K, Saleh D, Bayan F, Emoto N, Kaw S, Yanagisawa M, Giaid A.

Am J Respir Cell Mol Biol. 1996 Mar;14(3):248-53.

PMID:
8845175
12.

ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1.

Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M.

Cell. 1994 Aug 12;78(3):473-85.

PMID:
8062389
13.

The metabolism of endothelin-1 and big endothelin-1 by the isolated perfused kidney of the rabbit.

Kaw S, Warner TD, Vane JR.

J Cardiovasc Pharmacol. 1993;22 Suppl 8:S65-8.

PMID:
7510001
15.
16.

Characterization of serine protease-derived metabolites of big endothelin in the cytosolic fraction from human polymorphonuclear leukocytes.

Kaw S, Hecker M, Southan GJ, Warner TD, Vane JR.

J Cardiovasc Pharmacol. 1992;20 Suppl 12:S22-4.

PMID:
1282976
17.

The biosynthesis of endothelin-1 by human polymorphonuclear leukocytes.

Sessa WC, Kaw S, Hecker M, Vane JR.

Biochem Biophys Res Commun. 1991 Jan 31;174(2):613-8.

PMID:
1993057
18.

Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases.

Sessa WC, Kaw S, Zembowicz A, Anggård E, Hecker M, Vane JR.

J Cardiovasc Pharmacol. 1991;17 Suppl 7:S34-8.

PMID:
1725374
19.

Maturational changes of theophylline pharmacokinetics in preterm infants.

Dothey CI, Tserng KY, Kaw S, King KC.

Clin Pharmacol Ther. 1989 May;45(5):461-8.

PMID:
2721102

Supplemental Content

Support Center